Protenium Clinical Research (Hurst, TX) is currently seeking volunteers who are at high risk of SARS-CoV-2 infection to participate in a clinical trial to evaluate an investigation drug for prevention of the SARS-CoV-2 infection.
Our team of researchers are now enrolling adults and adolescent who have not previously tested positive for SARS-CoV-2 infection and who are at high risk for COVID-19, to participate in a clinical trial consisting of up to 15 visits over a period of 14 months.
Those at high risk for SARS-CoV-2 include, but are not limited to, household contact or occupational/recreational exposure to an individual with a diagnosis of SARS-CoV-2 infection, or housing, recreational and/or social conditions that are likely to increase risk of exposure to SARS-CoV-2.
Participants will be asked to complete an e-Diary throughout the duration of the study.